P

Inventor

ZHU WENYU

US44 patents
⚠️ This page may combine multiple inventors who share the name “ZHU WENYU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

36 patents
US9181271B2Nov 10, 2015

Tricyclic fused thiophene derivatives as JAK inhibitors

INCYTE CORP105 citations99
US8993605B2Mar 31, 2015

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP34 citations98
US9334274B2May 10, 2016

N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

INCYTE CORP57 citations97
US8822511B2Sep 2, 2014

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP24 citations96
US10806785B2Oct 20, 2020

Immunomodulator compounds and methods of use

INCYTE CORP32 citations94
US10092570B2Oct 9, 2018

Heterocyclylamines as PI3K inhibitors

INCYTE CORP17 citations94
US9730939B2Aug 15, 2017

Heterocyclylamines as PI3K inhibitors

INCYTE CORP23 citations94
US9193733B2Nov 24, 2015

Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors

INCYTE CORP33 citations94
US10034864B2Jul 31, 2018

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP8 citations93
US9789094B2Oct 17, 2017

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP11 citations93
US9540347B2Jan 10, 2017

Pyridineamine compounds useful as Pim kinase inhibitors

INCYTE CORP19 citations93
US9320732B2Apr 26, 2016

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP14 citations93
US9556197B2Jan 31, 2017

Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors

INCYTE CORP19 citations92
US8951536B2Feb 10, 2015

N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase

INCYTE CORP25 citations92
US7141596B2Nov 28, 2006

Inhibitors of proteins that bind phosphorylated molecules

INCYTE CORP24 citations89
US11161850B2Nov 2, 2021

Fused pyrazine derivatives as A2A / A2B inhibitors

INCYTE CORP5 citations84
US10653677B2May 19, 2020

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP4 citations84
US10450296B2Oct 22, 2019

Heterocyclic compounds useful as Pim kinase inhibitors

INCYTE CORP6 citations84
US10370387B2Aug 6, 2019

Tricyclic fused thiophene derivatives as JAK inhibitors

INCYTE CORP6 citations84
US10369137B2Aug 6, 2019

1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP5 citations84
US10000507B2Jun 19, 2018

Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors

INCYTE CORP12 citations84
US9920032B2Mar 20, 2018

Heterocyclic compounds useful as pim kinase inhibitors

INCYTE CORP12 citations84
US9908895B2Mar 6, 2018

Tricyclic fused thiophene derivatives as JAK inhibitors

INCYTE CORP8 citations84
US9777017B2Oct 3, 2017

Tricyclic fused thiophene derivatives as JAK inhibitors

INCYTE CORP9 citations84
US11851442B2Dec 26, 2023

Tricyclic fused thiophene derivatives as JAK inhibitors

INCYTE CORP1 citations73
US11207302B2Dec 28, 2021

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

INCYTE CORP1 citations73
US11161855B2Nov 2, 2021

Tricyclic fused thiophene derivatives as JAK inhibitors

INCYTE CORP3 citations73
US11530218B2Dec 20, 2022

Spiro compounds as inhibitors of KRAS

INCYTE CORP3 citations71
US12030884B2Jul 9, 2024

Pyrazoloquinoline KRAS inhibitors

INCYTE CORP0 citations63
US11053215B2Jul 6, 2021

Heterocyclic compounds useful as Pim kinase inhibitors

INCYTE CORP1 citations63
US11939328B2Mar 26, 2024

Quinoline compounds as inhibitors of KRAS

INCYTE CORP0 citations61
US11999740B2Jun 4, 2024

Fused pyrazine derivatives as A2A / A2B inhibitors

INCYTE CORP0 citations59
US12378243B2Aug 5, 2025

Quinoline compounds as inhibitors of KRAS

INCYTE CORP0 citations56
US12466822B2Nov 11, 2025

Heterocyclic compounds as immunomodulators

INCYTE CORP0 citations51
US12060433B2Aug 13, 2024

CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy

INCYTE CORP0 citations49
US12030883B2Jul 9, 2024

Hetero-tricyclic compounds as inhibitors of KRAS

INCYTE CORP0 citations49

COMBS ANDREW P

3 patents

RODGERS JAMES D

3 patents

COMBS ANDREW PAUL

2 patents